PT1315740E - Método para solubilizar e purificar proteínas recombinantes expressas como agregados insolúveis - Google Patents
Método para solubilizar e purificar proteínas recombinantes expressas como agregados insolúveis Download PDFInfo
- Publication number
- PT1315740E PT1315740E PT01967286T PT01967286T PT1315740E PT 1315740 E PT1315740 E PT 1315740E PT 01967286 T PT01967286 T PT 01967286T PT 01967286 T PT01967286 T PT 01967286T PT 1315740 E PT1315740 E PT 1315740E
- Authority
- PT
- Portugal
- Prior art keywords
- insoluble aggregates
- purifying
- different forms
- expressed
- recombinant bet
- Prior art date
Links
- 239000013566 allergen Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 2
- 210000003000 inclusion body Anatomy 0.000 abstract 2
- 238000000746 purification Methods 0.000 abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 239000003480 eluent Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000006386 neutralization reaction Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10044360A DE10044360A1 (de) | 2000-09-08 | 2000-09-08 | Verfahren zur Aufreinigung von rekombinanten als unlösliche Aggregate exprimierte Proteinen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1315740E true PT1315740E (pt) | 2009-12-29 |
Family
ID=7655449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01967286T PT1315740E (pt) | 2000-09-08 | 2001-08-18 | Método para solubilizar e purificar proteínas recombinantes expressas como agregados insolúveis |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6900034B2 (https=) |
| EP (1) | EP1315740B1 (https=) |
| JP (1) | JP5174312B2 (https=) |
| CN (1) | CN1468255A (https=) |
| AT (1) | ATE443712T1 (https=) |
| AU (2) | AU2001287695B2 (https=) |
| CA (1) | CA2421438C (https=) |
| DE (2) | DE10044360A1 (https=) |
| ES (1) | ES2333939T3 (https=) |
| HU (1) | HUP0303554A2 (https=) |
| PL (1) | PL206158B1 (https=) |
| PT (1) | PT1315740E (https=) |
| RU (1) | RU2299214C2 (https=) |
| WO (1) | WO2002020559A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2333951T5 (es) * | 2002-02-27 | 2017-11-16 | Merck Patent Gmbh | Método para producir alergenos principales rBet v 1 hipoalergénicos de abedul |
| CA2487673C (en) * | 2003-12-02 | 2010-11-02 | F. Hoffmann-La Roche Ag | Improved method for the recombinant production and purification of protein kinases |
| EP2323485B1 (en) * | 2008-08-08 | 2013-10-16 | Janssen Pharmaceutica, N.V. | Anti-allergen combinations of calcium and lanthanum salts |
| PL2721051T3 (pl) | 2011-06-15 | 2018-05-30 | Asit Biotech S.A. | Sposób wytwarzania hydrolizowanych alergenów |
| CN104558100A (zh) * | 2015-02-04 | 2015-04-29 | 吉林农业大学 | 包涵体的预处理方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4734362A (en) * | 1986-02-03 | 1988-03-29 | Cambridge Bioscience Corporation | Process for purifying recombinant proteins, and products thereof |
| US5101018A (en) * | 1989-06-12 | 1992-03-31 | International Minerals & Chemical Corp. | Method for recovering recombinant proteins |
| ATE113060T1 (de) | 1989-12-05 | 1994-11-15 | American Cyanamid Co | Methode zur auflösung und naturation von somatotropin unter verwendung von einer niedrigen harnstoffkonzentration. |
| US5912327A (en) | 1996-09-30 | 1999-06-15 | Human Genome Sciences, Inc. | Method of purifying chemokines from inclusion bodies |
| SE9703531D0 (sv) * | 1997-09-30 | 1997-09-30 | Rudolf Valenta | Non-anaphlactic forms of allergens and their use |
-
2000
- 2000-09-08 DE DE10044360A patent/DE10044360A1/de not_active Withdrawn
-
2001
- 2001-08-18 JP JP2002525179A patent/JP5174312B2/ja not_active Expired - Fee Related
- 2001-08-18 AU AU2001287695A patent/AU2001287695B2/en not_active Ceased
- 2001-08-18 AU AU8769501A patent/AU8769501A/xx active Pending
- 2001-08-18 HU HU0303554A patent/HUP0303554A2/hu unknown
- 2001-08-18 CN CNA018153550A patent/CN1468255A/zh active Pending
- 2001-08-18 WO PCT/EP2001/009552 patent/WO2002020559A1/de not_active Ceased
- 2001-08-18 AT AT01967286T patent/ATE443712T1/de active
- 2001-08-18 ES ES01967286T patent/ES2333939T3/es not_active Expired - Lifetime
- 2001-08-18 CA CA2421438A patent/CA2421438C/en not_active Expired - Fee Related
- 2001-08-18 EP EP01967286A patent/EP1315740B1/de not_active Expired - Lifetime
- 2001-08-18 US US10/363,788 patent/US6900034B2/en not_active Expired - Lifetime
- 2001-08-18 RU RU2003109430/13A patent/RU2299214C2/ru not_active IP Right Cessation
- 2001-08-18 PL PL359713A patent/PL206158B1/pl unknown
- 2001-08-18 DE DE50115119T patent/DE50115119D1/de not_active Expired - Lifetime
- 2001-08-18 PT PT01967286T patent/PT1315740E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE50115119D1 (de) | 2009-11-05 |
| DE10044360A1 (de) | 2002-03-21 |
| JP2004508384A (ja) | 2004-03-18 |
| JP5174312B2 (ja) | 2013-04-03 |
| EP1315740B1 (de) | 2009-09-23 |
| AU8769501A (en) | 2002-03-22 |
| WO2002020559A1 (de) | 2002-03-14 |
| CA2421438A1 (en) | 2003-03-06 |
| PL359713A1 (en) | 2004-09-06 |
| ATE443712T1 (de) | 2009-10-15 |
| AU2001287695B2 (en) | 2006-10-05 |
| CN1468255A (zh) | 2004-01-14 |
| US20030170815A1 (en) | 2003-09-11 |
| CA2421438C (en) | 2010-10-26 |
| RU2299214C2 (ru) | 2007-05-20 |
| ES2333939T3 (es) | 2010-03-03 |
| EP1315740A1 (de) | 2003-06-04 |
| HUP0303554A2 (hu) | 2004-03-01 |
| US6900034B2 (en) | 2005-05-31 |
| PL206158B1 (pl) | 2010-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG149000A1 (en) | Gag binding proteins | |
| AU2001264811A1 (en) | Methods for genetic analysis of dna to detect sequence variances | |
| WO2004110360A3 (en) | Proteoglycan degrading mutants for treatment of cns | |
| AU2003210687A1 (en) | Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa | |
| WO2005056585A3 (en) | Sars coronavirus s proteins and uses thereof | |
| AU2002249787A1 (en) | Compositions and methods relating to lung specific genes and proteins | |
| PT1315740E (pt) | Método para solubilizar e purificar proteínas recombinantes expressas como agregados insolúveis | |
| EP0826774A3 (en) | Staphylococcal Fab I enoyl-ACP reductase | |
| EP0834568A3 (en) | Novel saliva binding protein | |
| AU2001231086A1 (en) | Method of affinity purifying proteins using modified bis-arsenical fluorescein | |
| HRP20040795A2 (en) | Production process of recombinant placental growth factor | |
| WO2005019471A3 (en) | Periostin-like factor: compositions and methods for making and using the same | |
| AU6233501A (en) | Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide | |
| AU2003216186A1 (en) | System and method for facilitating candidate and subject participation in clinical trial studies | |
| AU2001287695A1 (en) | Method for purifying recombinant proteins expressed as insoluble aggregates | |
| WO2001036463A3 (en) | Genes specifically expressed in human dendritic cells | |
| AU2004206257A8 (en) | Human SAA3 nucleic acid molecule, protein, and methods of use for same | |
| AU2002235758A1 (en) | Alternative pol k nucleotide and amino acid sequence and methods for using | |
| DE60218463D1 (de) | Untereiheitsimpfstoffe und verfahren zur deren herstellung | |
| AU2002237733A1 (en) | Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) | |
| AU2003268651A1 (en) | Method of purifying protein complex, assay method, purification device and assay device | |
| AU2002241730A1 (en) | Compositions and methods relating to lung specific genes and proteins | |
| WO2003027639A3 (en) | Glucocorticoid receptor nuclear translocation domain | |
| AU2002331780A1 (en) | Compositions and methods relating to lung specific genes and proteins | |
| EP0846766A3 (en) | IgA Fc binding protein from Streptococcus pneumoniae |